Ethical dimensions of Huntington disease and genetic testing

Notice: Blog posts are not subject to review by MedLink Neurology’s Editorial Board. MedLink acknowledges using artificial intelligence to assist in the creation of blog posts.

Huntington disease is a genetic neurodegenerative disorder with profound ethical implications, particularly when it comes to presymptomatic genetic testing. Since the identification of the HTT gene mutation in 1993, genetic testing has offered individuals at risk the ability to know whether they will develop Huntington disease before symptoms arise. However, this knowledge comes with significant ethical, psychological, and societal challenges that affect not only the individual but also their family, future children, and society at large.

Presymptomatic diagnosis: a double-edged sword

Presymptomatic testing for Huntington disease allows at-risk individuals—those with a parent diagnosed with Huntington disease—to determine if they carry the expanded CAG repeat in the HTT gene. Although some find relief in knowing their genetic status, others may experience profound psychological stresses.

Psychological and emotional impact

• Knowledge of an unchangeable future. Testing positive for the Huntington disease mutation can lead to depression, anxiety, and existential distress, especially given the lack of a cure or disease-modifying therapies. Conversely, testing negative may result in “survivor’s guilt” for individuals who escape the mutation while siblings or relatives do not.
• Decisions about reproductive choices. Those who test positive face complex decisions about family planning. Techniques like preimplantation genetic diagnosis allow embryos to be screened for the Huntington disease mutation, but these methods raise ethical questions about the extent to which we should intervene in genetic inheritance.

Implications for families

Genetic testing for Huntington disease has a ripple effect on family members, regardless of the results.

• Intergenerational concerns. Children of individuals who test positive for the Huntington disease mutation may grow up knowing they have a 50% chance of inheriting the disease, potentially affecting their mental health and life choices.
• Disclosure dilemmas. Families often grapple with whether, when, and how to share genetic information. For example, should a parent inform their child of their genetic risk, and at what age?

Discrimination risks: insurance and employment

The potential for genetic discrimination is one of the most significant societal concerns related to Huntington disease testing.

• Insurance discrimination. In many countries, genetic information could potentially be used to deny health, life, or disability insurance. Although legislation like the Genetic Information Nondiscrimination Act (GINA) in the United States prohibits such practices, loopholes remain—for example, GINA does not cover life or long-term care insurance.
• Employment discrimination. Employers could misuse genetic information to deny opportunities or workplace accommodations, though this practice is generally illegal in many jurisdictions.

These concerns may deter individuals from pursuing genetic testing, even when it could inform important life decisions.

Broader ethical considerations

• Informed consent. Ensuring individuals fully understand the implications of genetic testing is critical. This includes the potential emotional toll, effects on family relationships, and long-term consequences of knowing their genetic fate.
• Access to testing and counseling. Not all individuals at risk for Huntington disease have equal access to genetic testing or genetic counseling services, exacerbating disparities in care. Comprehensive pre- and post-test counseling is essential to help individuals process the results and make informed decisions.
• Autonomy and privacy. The decision to undergo genetic testing must respect the individual’s autonomy, free from coercion by family members or medical providers. Additionally, maintaining strict confidentiality of genetic information is paramount to protect individuals from discrimination or stigma.

Navigating the ethical landscape

Although genetic testing for Huntington disease offers unprecedented opportunities for individuals to plan their lives and families, it also presents profound ethical challenges. Balancing the benefits of genetic knowledge with the risks of psychological harm, family strain, and societal discrimination requires careful consideration.

To address these challenges, neurologists and genetic counselors must provide robust support systems, clear communication, and advocacy for policies that protect individuals from discrimination. As research advances toward treatments and, potentially, cures for Huntington disease, ongoing dialogue about the ethical dimensions of genetic testing will remain critical to ensuring the well-being of those affected by this devastating disease.

Ultimately, the story of Huntington disease reflects broader questions about how society navigates the promises and perils of genetic technology.

Are you interested in contributing a post or becoming a guest blogger for MedLink? Contact us at editorial@medlink.com.